Myra Vision
Campbell
About Myra Vision
Myra Vision develops a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma. It seeks to provide IOP control and fill gaps in therapies for people with moderate to severe glaucoma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $50.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2023)
- Website: myravision.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/myra-vision-35802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.